[PLX] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
01-May-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 6.71%
YoY- 43.90%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 10,345 35,075 9,588 8,617 14,183 8,753 16,085 -25.47%
PBT -1,719 19,647 -2,936 -3,210 -3,567 -5,334 -2,286 -17.29%
Tax 133 308 195 530 442 -190 416 -53.21%
NP -1,852 19,339 -3,131 -3,740 -4,009 -5,144 -2,702 -22.24%
Tax Rate - -1.57% - - - - - -
Total Cost 12,197 15,736 12,719 12,357 18,192 13,897 18,787 -25.00%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -17.90 55.14 -32.66 -43.40 -28.27 -58.77 -16.80 4.31%
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -0.03 0.29 -0.05 -0.07 -0.08 -0.11 -0.06 -36.97%
EPS Diluted -0.02 0.21 -0.05 -0.07 -0.08 -0.11 -0.06 -51.89%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.